https://www.selleckchem.com/pr....oducts/gsk2193874.ht
036). The cardiac index in the combination group tended to be preserved compared to that in the control (P = 0.06). The pathological fibrotic area in the left ventricle in the combination group also tended to be smaller (P = 0.08). Combination therapy with linagliptin and empagliflozin preserved cardiac systolic function on the diabetes mice model of myocardial ischemia-reperfusion injury independent of blood glucose levels. Combination therapy with linagliptin and empagliflozin preserved cardiac systolic function on the diabetes mic
Like
Comment
Share
